Quantum Discovery
Quantum Discovery Labs is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services, and pursue our own in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and anti-cancer efficacy.
Quantum@linkedin.com
Contacts: office@q-pharm.com or comment any post on the site. You are welcome!
Quantum on Google+
Latest Headlines
-
![Recently, RecA has established itself as a potential target for the development of antibacterial drugs. The dual function of recA allows bacteria both to control the damage associated with the [...]](http://q-pharm.com/wp-content/uploads/2010/07/recAhits.png "New inhibitors of RecA (bacterial SOS response system) identified.")
New inhibitors of RecA (bacterial SOS response system) identified.
Posted on July 14, 2010 | 2 CommentsRecently, RecA has established itself as a potential target for the development of antibacterial drugs. The dual function of recA allows bacteria both to control the damage associated with the [...] -
“Quantum” roadmap to computational drug discovery
Posted on July 6, 2010 | No CommentsTalk @ Moscow State University, French-Russian workshop in Chemoinformatics. Moscow -
Talk@MIPT (in Russian)
Posted on July 6, 2010 | No CommentsThe talk was given to the MIPT freshmen, this is a heavily adapted and augmented version of “Water as a ferroelectric…” presentation at MIPT, “Water as a segnetoelectric, anomalous [...] -
Bactericidal activity study of the newest anti-tuberculosis compound QP-42 completed
Posted on June 14, 2010 | No CommentsEvaluation of bactericidal activity (ability to cause the death of the microorganism) of the substance QP42 in vitro was determined in the automated system Bactec MGIT 960. The precipitate the [...] -
![The situation with drug resistant forms of tuberculosis (TB), aka MDR and XDR forms, remains increasingly troubling. XDR form was originally identified in 2006 and by now comprising up to [...]](http://q-pharm.com/wp-content/uploads/2010/06/tb.png "Quantum tests a novel targeted anti-tuberculosis compound")
Quantum tests a novel targeted anti-tuberculosis compound
Posted on June 5, 2010 | No CommentsThe situation with drug resistant forms of tuberculosis (TB), aka MDR and XDR forms, remains increasingly troubling. XDR form was originally identified in 2006 and by now comprising up to [...]